Inventor · disambiguated record
Dirk Schneider
Also filed as: SCHNEIDER DIRK
12 granted patents·15 pending applications·87 citations·filing 2007–2016
90Inventor score
Files withBayer Pharma AG12BAYER SCHERING PHARMA AG3HEIMBACH DIRK3HAHN MICHAEL2VAKALOPOULOS ALEXANDROS2
Top patents by PatentIndex Score
27 records- 0190US8778964B2Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Jul 15, 2014·15 cites·6 claims
- 0288US8796305B2Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Aug 5, 2014·14 cites·6 claims
- 0388US8119663B2Heteroaryl-substituted piperidinesHEIMBACH DIRK·Filed 2008·Granted Feb 21, 2012·16 cites·8 claims
- 0487US8946215B2Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Feb 3, 2015·10 cites·8 claims
- 0587US8217063B2Lactam-substituted dicarboxylic acids and use thereofHAHN MICHAEL·Filed 2008·Granted Jul 10, 2012·6 cites·11 claims
- 0683US8084481B2Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsMEIER HEINRICH·Filed 2007·Granted Dec 27, 2011·11 cites·11 claims
- 0783US7985876B2Substituted dibenzoic acid derivatives and use thereofBAYER SCHERING PHARMA AG·Filed 2008·Granted Jul 26, 2011·6 cites·9 claims
- 0880US8691817B2Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereofVON NUSSBAUM FRANZ·Filed 2010·Granted Apr 8, 2014·6 cites·9 claims
- 0975US8987256B2Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereofHAHN MICHAEL·Filed 2009·Granted Mar 24, 2015·2 cites·10 claims
- 1074US8987248B2Substituted piperidines as Par-1 antagonistsJESKE MARIO·Filed 2010·Granted Mar 24, 2015·1 cites·9 claims
- 1156US2016362408A1Aryl- and hetaryl-substituted imidazo[1,2-a]pyridine-3-carboxamides and use thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1251US9187428B2Substituted dicyanopyridines and use thereofVAKALOPOULOS ALEXANDROS·Filed 2011·Granted Nov 17, 2015·0 cites·5 claims
- 1351US2010099681A1Substituted 5-aminopyrazoles and use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 1450US2015183773A1Substituted piperidinesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 1547US2010105663A12-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitorsBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 1646US2013005704A1Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsBAYER PHARMA AKTIENGESELLSHAFT·Filed 2011·Application pending·0 cites
- 1745US2012214788A1Heteroaryl-substituted piperidinesHEIMBACH DIRK·Filed 2012·Application pending·0 cites
- 1845US2010105673A1Substituted aminofuranones and their useBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 1942US10130633B2CompoundsBayer Pharma AG·Filed 2014·Granted Nov 20, 2018·0 cites·17 claims
- 2042US2016052898A1Novel compoundsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2141US2016130230A1Substituted dicyanopyridines and use thereofVAKALOPOULOS ALEXANDROS·Filed 2015·Application pending·0 cites
- 2235US2012129831A1Substituted 3-(1,2,4-Oxadiazol-5-yl)-5-PhenylpiperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
- 2333US2018044306A11,3,4-thiadiazol-2-yl-benzamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2433US2018042931A1N-phenyl-(morpholin-4-yl or piperazinyl)acetamide derivatives and their use as inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2533US2018028507A13-carbamoylphenyl-4-carboxamide and isophtalamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2631US2017107212A1Novel compoundsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2731US2017114070A1Inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dirk Schneider files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →